Mitigating the associations of kidney dysfunction with blood biomarkers of Alzheimer disease by using phosphorylated tau to total tau ratios

Authors

Shorena Janelidze, Lund University
Nicolas R Barthélemy, Washington University School of Medicine in St. Louis
Yingxin He, Washington University School of Medicine in St. Louis
Randall J Bateman, Washington University School of Medicine in St. Louis
Oskar Hansson, Lund University

Journal

JAMA Neurology

Publication Date

5-1-2023

Volume

80

Issue

5

First Page

516

Last Page

522

Document Type

Open Access Publication

DOI

10.1001/jamaneurol.2023.0199

Rights and Permissions

Janelidze S, Barthélemy NR, He Y, Bateman RJ, Hansson O. Mitigating the Associations of Kidney Dysfunction With Blood Biomarkers of Alzheimer Disease by Using Phosphorylated Tau to Total Tau Ratios. JAMA Neurol. 2023;80(5):516–522. doi:10.1001/jamaneurol.2023.0199. This is an open access article distributed under the terms of the CC-BY License. © 2023 Janelidze S et al. JAMA Neurology.

Recommended Citation

Janelidze, Shorena; Barthélemy, Nicolas R; He, Yingxin; Bateman, Randall J; and Hansson, Oskar, "Mitigating the associations of kidney dysfunction with blood biomarkers of Alzheimer disease by using phosphorylated tau to total tau ratios." JAMA Neurology. 80, 5. 516 - 522. (2023).
https://digitalcommons.wustl.edu/oa_4/4551

Department

ICTS (Institute of Clinical and Translational Sciences)

Additional Links

Supplemental material is available for this article at publisher site.